Combigene AB specialized in developing gene therapies for neurological diseases, focusing on treatments for epileptic seizures and chronic pain. The company combined neuroscience and genetic engineering to advance novel therapies in Sweden.

Combigene Logo

Logos are displayed for identification only. Logokit is not affiliated with, endorsed by, or sponsored by the companies shown.

About Combigene

Combigene AB specialized in the development of gene therapies for severe neurological diseases, focusing on treatments for epileptic seizures and chronic pain conditions. The company combined neuroscience and genetic engineering to develop novel therapies, including adeno-associated virus-based gene therapies and peptide treatments. Combigene operated in Sweden and collaborated with partners to advance its research programs.

Address

Agavagen 52A
Lidingö, 181 55
Sweden

Year founded

1990

Number of employees

0-100

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Add Combigene logo and brand data to your app or website

Embed this logo using a simple HTML tag, or access structured brand data with a single call to our API.

<img src="https://img.logokit.com/combigene.com" />

Report inaccurate data

Request an update to help us keep the brand up-to-date.

One API,
Millions of Logos

Get Started Contact Us
One API, Millions of Logos